The panel were blown away by the pitches from the entrepreneurs, with wide-ranging innovations including a health platform for children, a home test for monitoring iron levels, wound dressing and a patented medical device. After careful consideration, the panel announced Astinno as the winner of the programme, whose venture they felt offered the strongest solution. Astinno was awarded a package of business support worth up to £100k.
The London based startup is creating a femtech hardware solution for women experiencing one of the most debilitating symptoms associated with menopause. “Grace” is a smart bracelet using specialist cooling technology to automatically detect and counter menopausal hot flushes night and day.
Pioneers tested their concepts with expert mentors from industry, investment, and healthcare sectors over the eight-week Accelerator programme. This year’s programme ran virtually with sessions and online support provided by the BioCity platform, adapted to suit the restrictions imposed by Covid-19.
Peter Astbury, Founder of Astinno said, “Being 3 years into my start-up journey, I was initially hesitant to take part in an Accelerator as I was worried we might be too far along in our development to gain maximum benefit from this type of programme. I needn’t have worried – in the last 8 weeks we’ve had fantastic coaching from BioCity, uncovering lots of valuable insights and re-enforcing a lot of our early research which now provides us with an even stronger focus and proposition for those customers we’re looking to help.”
“Menopause is an area that has experienced somewhat of a cultural shift in the last few years and this has been realised and evidenced in our new research. Huge thanks go to BioCity and AHSN for supporting us with this. It just shows that Accelerators aren’t only suited to those with the seed of an idea but also companies that have already made significant progress on their business and product/service.”
Toby Reid, CEO of BioCity Group, said: “This Autumn, the Accelerator programme has seen ventures of an exceptional standard. Astinno is a brilliant example of an innovation that has been further strengthened by our partnership with East Midlands AHSN. We are delighted to have announced Astinno as the winner of this programme and look forward to supporting their continued success.”
The search for life-science pioneers will continue in the new year, as the next EMAHSN Pre-Accelerator programme launches in February 2021. More information here https://biocity.co.uk/accelerator-programmes/